Taiwan Pharmaceuticals & Healthcare Report Q2 2018
Despite its small relative size, we remain positive about the Taiwanese pharmaceutical market's short-to-medium termpotential. Key factors supporting the growth of the already strong prescription market segment are a strong preference for patenteddrugs, a mature chronic disease profile and the fact that hospitals act as key points of healthcare access. However, as in otherdeveloped markets, the forecasts remain at downside risk from authorities' attempts to control healthcare expenditure and torationalise access to secondary healthcare services.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook